4th Translational Research Conference: Chronic Lymphocytic Leukaemia (CLL)

European School of Haematology (ESH) 4^th Translational Research Conference on Chronic Lymphocytic Leukaemia (ESHCLL2026) is organized by European School of Haematology (ESH) and will be held from Mar 05 - 07, 2026 at Clarion Hotel Stockholm, Stockholm, Sodermanland, Sweden.

Description:
This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training.

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.

Scientific Topics:

• Spectrum of CLL – one disease or more
• Richter transformation
• Drivers of disease progression – from genetics, epigenetics, and proteomics (complexity of the evolution)
• The microenvironment of CLL
• Time limited therapies: which combination? which duration? which markers to stop therapy?
• BTK inhibition or degradation?
• The new challenge: resistance to one or two inhibitor classes? – Double refractory CLL
• Future therapies, new compounds
• Directions and strategies to use the best agents in the optimal way: sequencing, combinations, costs of therapy, availability

Learning Objectives:
Upon completion of this CME activity, participants include:

• Understand recent advances in elucidating the pathogenesis of CLL
• Describe recent data on therapeutic regimens for CLL
• Understand emerging data on mechanisms of resistance to targeted agents in CLL
• Understand the debate about how best to optimize CLL therapy in the future